Picture Kentro Design Corporate and Web Design Berlin 650x65px

Financing › Details

Alexion–AstraZeneca: investment, 202012– acquisition $39b with $13.4b in cash + $25.6b in ADSs Alexion shareholders will own 15% of combined firm

	Period	2020-12-12
	Money taker	Alexion Pharmaceuticals Inc. (Nasdaq: ALXN)
	Group	Alexion (Group)
	Money source	AstraZeneca plc (LSE: AZN)
	Group	AstraZeneca (Group)
	Product	DRUGS, ORPHAN
	Product 2	pharmaceutical
	Source	AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]".

Record changed: 2020-12-15

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Alexion (Group)

[1] AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]"....
[2] MorphoSys AG. (6/24/19). "Press Release: MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer". Planegg....
[3] Erytech Pharma. (5/6/19). "Press Release: Erytech Proposes the Appointment of Dr. Jean-Paul Kress as Chairman of the Board of Directors". Lyon....
[4] Hookipa Pharma Inc.. (11/14/18). "Press Release: Hookipa Appoints Julie O’Neill as a Non-Executive Director". New York, NY & Vienna....
[5] Abingworth LLP. (7/9/18). "Press Release: Abingworth Raises $315m for ABV VII 12th Life Sciences Fund". London....
[6] Alexion Pharmaceuticals, Inc.. (5/25/18). "Press Release: Alexion Offer for Wilson Therapeutics Accepted". New Haven, CT....
[7] Alexion Pharmaceuticals, Inc.. (4/11/18). "Press Release: Alexion to Acquire Wilson Therapeutics". New Haven, CT....
[8] Argen-X N.V. (Argenx). (4/9/18). "Press Release: Argenx Appoints Keith Woods as Chief Operating Officer". Breda & Ghent....
[9] Abeona Therapeutics Inc.. (4/2/18). "Press Release: Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer". New York, NY & Cleveland, OH....
[10] Wilson Therapeutics AB. (12/14/17). "Press Release: WTX101 Granted Fast Track Designation by the U.S. FDA for the Treatment of Wilson Disease"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]